Research Analysts’ Recent Ratings Changes for Albemarle (ALB)

A number of research firms have changed their ratings and price targets for Albemarle (NYSE: ALB):

• 8/18/2026 – Albemarle was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 8/15/2026 – Albemarle was downgraded by Wall Street Zen from “buy” to “hold”.
• 8/10/2026 – Albemarle had its price target lowered by Scotiabank from $200.00 to $190.00. They now have a “sector outperform” rating on the stock.
• 8/10/2026 – Albemarle had its price target lowered by Royal Bank Of Canada from $166.00 to $157.00. They now have an “outperform” rating on the stock.
• 8/10/2026 – Albemarle had its “reduce” rating reaffirmed by Morgan Stanley. They now have a $161.00 price target on the stock.
• 8/7/2026 – Albemarle had its price target lowered by UBS Group AG from $205.00 to $175.00. They now have a “buy” rating on the stock.
• 8/7/2026 – Albemarle had its price target lowered by Citigroup Inc. from $225.00 to $175.00. They now have a “buy” rating on the stock.
• 8/7/2026 – Albemarle had its price target lowered by Truist Financial Corporation from $245.00 to $225.00. They now have a “buy” rating on the stock.
• 8/4/2026 – Albemarle had its “sell (d+)” rating reaffirmed by Weiss Ratings.
• 8/1/2026 – Albemarle was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 7/28/2026 – Albemarle had its “outperform” rating reaffirmed by Scotiabank.
• 7/28/2026 – Albemarle had its price target lowered by Scotiabank from $215.00 to $200.00. They now have a “sector outperform” rating on the stock.
• 7/20/2026 – Albemarle was downgraded by Zacks Research from “strong-buy” to “hold”.
• 7/20/2026 – Albemarle had its price target lowered by Truist Financial Corporation from $260.00 to $245.00. They now have a “buy” rating on the stock.
• 7/17/2026 – Albemarle was given a new $166.00 price target by Royal Bank Of Canada.
• 7/13/2026 – Albemarle was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 7/5/2026 – Albemarle was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 7/1/2026 – Albemarle had its price target lowered by Rothschild & Co Redburn from $188.00 to $170.00. They now have a “neutral” rating on the stock.
• 7/1/2026 – Albemarle had its price target lowered by Mizuho from $205.00 to $185.00. They now have a “neutral” rating on the stock.
• 6/30/2026 – Albemarle had its price target lowered by Jefferies Financial Group Inc. from $244.00 to $211.00. They now have a “buy” rating on the stock.
• 6/27/2026 – Albemarle was upgraded by Wall Street Zen from “buy” to “strong-buy”.

Albemarle Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Friday, September 11th will be paid a $0.41 dividend. The ex-dividend date is Friday, September 11th. This represents a $1.64 dividend on an annualized basis and a yield of 1.1%. This is an increase from Albemarle’s previous quarterly dividend of $0.41. Albemarle’s dividend payout ratio is currently 607.41%.

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.